CORD-19:22616110b79baaf4c9d23f130a9ee35c64d991f7 / 464719-464945 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T375","span":{"begin":0,"end":226},"obj":"Sentence"}],"text":"Similarly, patients with COPD stage III-IV received more frequently high dose steroids 28/37 (76%) vs 11/32 (34%), p \u003c 0,001, and had more frequently increased dyspnoea during admittance, 36/37 (97%) vs 20/32 (62%), p \u003c 0,001."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T7614","span":{"begin":0,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Similarly, patients with COPD stage III-IV received more frequently high dose steroids 28/37 (76%) vs 11/32 (34%), p \u003c 0,001, and had more frequently increased dyspnoea during admittance, 36/37 (97%) vs 20/32 (62%), p \u003c 0,001."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2659","span":{"begin":25,"end":29},"obj":"Disease"}],"attributes":[{"id":"A2659","pred":"mondo_id","subj":"T2659","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"}],"text":"Similarly, patients with COPD stage III-IV received more frequently high dose steroids 28/37 (76%) vs 11/32 (34%), p \u003c 0,001, and had more frequently increased dyspnoea during admittance, 36/37 (97%) vs 20/32 (62%), p \u003c 0,001."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T615","span":{"begin":25,"end":29},"obj":"Phenotype"},{"id":"T616","span":{"begin":160,"end":168},"obj":"Phenotype"}],"attributes":[{"id":"A615","pred":"hp_id","subj":"T615","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A616","pred":"hp_id","subj":"T616","obj":"http://purl.obolibrary.org/obo/HP_0002094"}],"text":"Similarly, patients with COPD stage III-IV received more frequently high dose steroids 28/37 (76%) vs 11/32 (34%), p \u003c 0,001, and had more frequently increased dyspnoea during admittance, 36/37 (97%) vs 20/32 (62%), p \u003c 0,001."}